机构:[1]Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Chinese Academyof Sciences, Kunming, China[2]Kunming College of Lifesciences, University of Chinese Academy Sciences, Kunming, China[3]State Key Laboratory of Medicinal ChemicalBiology, College of Life Sciences, Nankai University, Tianjin, China[4]College of Life Sciences, China University of Science and Technology, Hefei, Anhui, China[5]School ofChinese Materia Medica, Yunnan University of Chinese Medicine, Kunming, China[6]The First Affiliated Hospital, Kunming Medical University, Kunming, China昆明医科大学附属第一医院[7]The FirstAffiliated Hospital, Peking University, Beijing, China[8]Department of Oncology, Tongji Hospital of Tongji Medical College of Huazhong University of Science andTechnology, Wuhan, China华中科技大学同济医学院附属同济医院[9]School of Pharmaceutical Science, Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiamen, China[10]Department of Breast Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China[11]KIZ-CUHK Joint Laboratory of Bioresources and MolecularResearch in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
第一作者机构:[1]Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Chinese Academyof Sciences, Kunming, China[2]Kunming College of Lifesciences, University of Chinese Academy Sciences, Kunming, China
共同第一作者:
通讯作者:
通讯机构:[1]Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Chinese Academyof Sciences, Kunming, China[2]Kunming College of Lifesciences, University of Chinese Academy Sciences, Kunming, China[11]KIZ-CUHK Joint Laboratory of Bioresources and MolecularResearch in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China
推荐引用方式(GB/T 7714):
Dewei Jiang,Ting Qiu,Junjiang Peng,et al.YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer.[J].CELL DEATH AND DIFFERENTIATION.2022,29(6):1283-1295.doi:10.1038/s41418-021-00920-x.
APA:
Dewei Jiang,Ting Qiu,Junjiang Peng,Siyuan Li,Tala...&Ceshi Chen.(2022).YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer..CELL DEATH AND DIFFERENTIATION,29,(6)
MLA:
Dewei Jiang,et al."YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer.".CELL DEATH AND DIFFERENTIATION 29..6(2022):1283-1295